Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-22

FDA Approved: VALSARTAN — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA granted original approval for VALSARTAN (Valsartan) by Zydus Lifesciences Limited as a generic product under ANDA 218991.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

ORIG AP for VALSARTAN (VALSARTAN)